您当前的位置：
首页 >
文章列表页 >
Research advances on SGLT2 inhibitors in the prevention and treatment of anthracycline-related cardiotoxicity
Medical Journal of Chinese People′s Liberation Army   Pages: 1-7(2026)
更新时间：2026-04-20

    • Research advances on SGLT2 inhibitors in the prevention and treatment of anthracycline-related cardiotoxicity

    • DOI：10.11855/j.issn.0577-7402.2064.2026.0416    

      CLC： R730.53;R54

    • Received：14 August 2025，

      Accepted：07 October 2025，

      Online First：19 April 2026，

    移动端阅览

  • Wang Yu-Bo,Wang Hai-Xia,Du Shu-Zhen,et al.Research advances on SGLT2 inhibitors in the prevention and treatment of anthracycline-related cardiotoxicity[J].Medical Journal of Chinese People′s Liberation Army, DOI：10.11855/j.issn.0577-7402.2064.2026.0416.

  •  
  •  

0

Views

0

下载量

0

CSCD

0

CNKI被引量

>
Alert me when the article has been cited
提交
Outline
No Sections

Related Articles

Experimental research on recombinant human endostatin-induced cardiomyocyte apoptosis in rats

Related Author

QIN Jing
QIAN Xin-yu
LU Hui-qi
HAN Huan-xing
LUO Rong-cheng

Related Institution

Department of Chemotherapy,Zhejiang Cancer Hospital
Department of Oncology,Hangzhou First People’s Hospital
Department of Laboratory Medicine,Changzheng Hospital,Second Military Medical University
Department of Oncology,Nanfang Hospital,Southern Medical University
0